|
Commonwealth Biotechnologies, Inc. - Comparative Business Analysis Snapshot
Business Description
Commonwealth Biotechnologies, Inc.. The Group's principal activity is to provide solutions to the global biotechnology industry, academic institutions, genetic identity, laboratory services, commercial contracts, government agencies and pharmaceutical companies. It provides integrated contract research support in four principal areas: bio-defense; laboratory support services for on-going clinical trials; comprehensive contract projects in the private sector; and through it FIL division, for paternity testing, forensic case-work analysis and CODIS work. The Group also provides sophisticated macromolecular synthetic and analytical services, integrating individual platform technologies. The Group facilitates strategic decisions to both short term and long term clients. It operates only in the United States. On 23-Sep-2008, the Group discontinued Exelgen Limited.
Competitor Analysis
This analysis compares Commonwealth Biotechnologies, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
